
Can MTAP deletion become an actionable Achilles’ heel in cancer? Pleased to share our review in The Oncologist on the MTAP–PRMT5 synthetic lethal axis: MTA-cooperative inhibitors, early clinical signals, biomarkers and resistance. @gbanna74 @OncJournal 🔗 doi.org/10.1093/oncolo/oyag4… kudos to the co-authors for their effort @Maxime_Borgeaud @mihaela_aldea dr Koessler and Dr Genoud @hug_ge @DOncologie


















































